Alnylam Pharmaceuticals · 16 hours ago
Senior Manager Clinical Operations
Alnylam Pharmaceuticals is a company focused on delivering innovative therapies. The Sr. Manager, Clinical Operations is responsible for the end-to-end clinical trial delivery, leading a cross-functional trial team, and ensuring trials are delivered on time, within budget, and compliant with regulations.
Responsibilities
Responsible for leading the Cross functional trial team to influence and execute delivery of the operational plan and for end-to-end trial execution
Accountable for overall trial delivery, budget, timelines, quality, and milestones (e.g., support DBL/ CSR/ TLR planning and scope, define protocol deviations and resolution pathways)
Oversight of all aspects of CRO/vendor identification, set up, statement of work creation, budget oversight and performance (KPI’s and metrics)
Proactively ensure that trial deliverables and milestones are met according to corporate and study-level goals
Identify risks and ensure mitigations and contingencies are being initiated and followed through
Ensure trial Is operationalized in compliance with global health authority regulations and guidelines and internal operating procedures and processes
Participate in preparation for, and conduct of, Health Authority Inspections and internal QA audits
Ensure that the trial team operates in a constant state of inspection-readiness, collaborating with R&D Quality to ensure quality oversight
Participate in process improvement activities at a trial and department level as needed
Mentor & support onboarding of new team members, particularly those in Study Management
Interface with internal key stakeholders including, but not limited to; Finance, Program Management, Vendor Management, Safety, Accounting, Supply, Quality Assurance, Data Management, Statistics, Clinical Research, Commercial, Regulatory, Bio Analytical, Medical Affairs; which may include acting as a liaison between groups
Provide a variance analysis of budget to actual and notify finance of projected cost over/under expenditure
Support and provide input into internal governance presentations & updates
Ability to travel approximately 10% but flexibility to go over or below as per business need)
Qualification
Required
BS/ BA degree is required
Minimum 7+ years of clinical research experience gained with a CRO, Biotech or Pharmaceutical Company working on Phase 1-4 global clinical trials
3-5 years leading end to end global clinical trials with experience in conducting Phase 3 registrational trials
Experience leading global trials outsourced to a CRO and ability to manage all aspects of execution of a clinical trial
Excellent decision-making, analytical and financial management skills are essential to this position
Excellent leadership skills, proven ability to foster team productivity and cohesiveness and the ability to operate and execute with limited supervision
Experience in leading without authority and in multifunctional matrixed and global environments
Experience mentoring/ coaching others
Exceptional organizational skills and ability to deal with competing priorities, also strong reasoning and problem-solving ability
Strong project planning/ management, communication (written and verbal) and presentation skills
Proficient with MS Office Suite (Excel, Word and PowerPoint) and MS Project
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
H1B Sponsorship
Alnylam Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (18)
2021 (19)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Recent News
2025-12-22
2025-12-20
Company data provided by crunchbase